Does my Singapore private company actually need a nominee director if I am the sole foreign shareholder?

The question is whether the company already has at least one director ordinarily resident in Singapore. If you hold an Employment Pass or EntrePass with a Singapore residential address, you can be the resident director yourself and no nominee is required. If your immigration status is pending or you are not in Singapore, the company must appoint a nominee resident director to satisfy Section 145(1) of the Companies Act until your immigration outcome lands.

Can my EP-holder employee be the resident director instead of a nominee?

Yes, provided the EP / EntrePass holder consents to the appointment, holds a Singapore residential address, and the appointment is consistent with the letter of consent terms governing their pass. ACRA's local-residency guidance allows EP and EntrePass holders to serve as directors with appropriate documentation. An employee director still owes the full Section 157 duties to the company, so the engagement should be documented with role scope and reporting structure.

What is the difference between a nominee director and a registered representative?

A nominee director is a director of the company appointed to satisfy the Section 145(1) resident-director requirement. A registered representative is the local agent appointed by a foreign company that maintains a branch registration in Singapore (a different statutory mechanism under Part 11 of the Companies Act). The two roles are not interchangeable: a Singapore-incorporated subsidiary requires a nominee director if it lacks a local resident director; a foreign company's Singapore branch requires a registered representative.

What happens if the nominee director resigns?

The company has 60 days after the resignation to appoint a replacement resident director and notify ACRA through Bizfile. If the company falls below the minimum of one resident director and does not remediate, ACRA can take enforcement action including striking off. The Central ROND must be updated within 2 business days of the cessation of the nominee status, separately from the standard director-change filing on Bizfile.

What are my Central ROND filing obligations as a nominator?

The lodgement obligation sits with the company, but the nominee must disclose the nominator's particulars to the company within 30 days of appointment and within 30 days of any change. The company then files with ACRA's Central ROND within 2 business days of receipt. Companies incorporated on or after 16 June 2025 with nominee directors lodge at incorporation through the Bizfile registration flow.

How does the CSPA 2024 change who can offer nominee director services?

From 9 June 2025, only Corporate Service Providers registered with ACRA may arrange nominee director appointments by way of business, and the CSP must assess each proposed nominee as fit and proper. Existing Registered Filing Agents transitioned to CSP registration. Foreign-controlled Singapore companies that previously used informal individual nominee arrangements must restructure to engage a registered CSP, or face exposure under the CSPA 2024.

How does Anlian Group's licensed corporate services team handle nominee director appointments?

Anlian Group's licensed corporate services team is registered with ACRA as a Corporate Service Provider under FA20200346 and can arrange nominee resident director appointments under the CSPA 2024 framework following a documented fit-and-proper assessment. Engagement scope is confirmed during the [strategy call](/contact/strategy-call) and covers the nominee appointment, private and Central ROND maintenance, scope-limited signing authority, and the ACRA filings that flow from nominee status changes. The companion piece on [CDD and AML under the CSPA 2024](/insights/cdd-aml-cspa-2024-corporate-service-providers) covers the CSP-side compliance perimeter.

Article

Singapore Nominee Director: Legal Framework, CSP Licence Posture, and What to Look For

In one sentence

A Singapore nominee director is a director appointed to satisfy Section 145(1) of the Companies Act 1967 (the statutory requirement that every company have at least one director ordinarily resident in Singapore) while the nominator retains substantive control of the company; the role is regulated under Section 386AC of the Companies Act and the Companies (Register of Controllers, Nominee Directors, Nominee Shareholders and Members of Foreign Companies) Regulations 2017, and from 9 June 2025 the Corporate Service Providers Act 2024 (CSPA 2024) prohibits anyone from acting as a nominee director by way of business unless the appointment is arranged by an ACRA-registered Corporate Service Provider that has assessed the nominee as fit and proper.

Quick answer

Section 145(1) of the Companies Act 1967 requires every Singapore-incorporated company to have at least one director who is "ordinarily resident in Singapore" (a Singapore citizen, Singapore permanent resident, or holder of an Employment Pass / EntrePass with a Singapore residential address), and a foreign-controlled company without a qualifying local director relies on a nominee director to meet this requirement.
Section 386AC of the Companies Act and the Companies Regulations 2017 require every company to maintain a private Register of Nominee Directors at its registered office or its appointed CSP's office; nominee directors must disclose their nominee status and nominator details to the company within 30 days of appointment and within 30 days of any change.
With effect from 16 June 2025, companies must also submit Register of Nominee Director information to ACRA's Central Register of Nominee Directors (Central ROND); the initial submission deadline was 31 December 2025 and subsequent updates must be filed within 2 business days. Nominee status is publicly displayed on the company's business profile; full nominator particulars are accessible to law enforcement.
With effect from 9 June 2025, the Corporate Service Providers Act 2024 prohibits persons from acting as nominee directors by way of business unless the appointment is arranged by a Corporate Service Provider registered with ACRA, and the CSP has assessed the proposed nominee as fit and proper on factors including fraud convictions, bankruptcy, compliance history, and competency to discharge director obligations.
A nominee director owes the company the same fiduciary, care-and-skill, and statutory duties under Section 157 of the Companies Act as any other director; an indemnity from the nominator is contractual and does not override the nominee's personal liability to creditors, regulators, or the company itself for breach of director duties.

Why this matters in 2026

The Singapore nominee director compliance perimeter changed substantially in 2025 and the implications are still settling in 2026. Three regulatory moves are the source of the change.

First, the Companies and Limited Liability Partnerships (Miscellaneous Amendments) Act 2024 (CLLPMA 2024) extended ACRA's Central Register of Nominee Directors (Central ROND) regime from a private register kept at the company's registered office to a centralised electronic filing on ACRA's Bizfile system. Companies and foreign companies that maintained Registers of Nominee Directors privately since 2017 must, with effect from 16 June 2025, also lodge that information with the Central ROND, with the initial deadline at 31 December 2025 and subsequent changes within 2 business days. The nominee status itself appears in the company's public business profile; full nominator particulars remain accessible to law enforcement under controlled access. Failure to lodge attracts a fine of up to S$25,000.

Second, the Corporate Service Providers Act 2024 commenced on 9 June 2025. The CSPA 2024 brings all corporate service providers in Singapore under a unified registration regime administered by ACRA, replacing the older Registered Filing Agent (RFA) framework. Most relevantly for nominee directors, the Act prohibits anyone from acting as a nominee director by way of business unless the appointment is arranged by an ACRA-registered CSP and the proposed nominee has been assessed as fit and proper by that CSP. The "by way of business" qualifier is broad: it covers professional nominee arrangements and excludes only one-off appointments by individuals who are not in the business of providing the service.

Third, the supervisory shift to AML / countering-financing-of-terrorism oversight at the CSP level means that nominee director arrangements now sit explicitly inside the AML perimeter. Each registered CSP is responsible for know-your-customer due diligence on the nominator, ongoing transaction monitoring, and suspicious transaction reporting to the Suspicious Transaction Reporting Office under the relevant statutes. The practical consequence is that a foreign-controlled Singapore company can no longer treat the resident-director slot as a paper formality. The companion piece on [CDD and AML under the CSPA 2024](/insights/cdd-aml-cspa-2024-corporate-service-providers) covers the CSP-side compliance perimeter in more detail; this article covers the nominee director role from the nominator's perspective.

The fundamentals

The Section 145(1) resident-director requirement and what "ordinarily resident" means

Section 145(1) of the Companies Act 1967 requires every Singapore-incorporated company to have at least one director who is ordinarily resident in Singapore, and ACRA's published guidance defines ordinarily resident as a Singapore citizen, Singapore permanent resident, or holder of an Employment Pass or EntrePass with a Singapore residential address; a director who is on the company's payroll under a work pass and who lives in Singapore satisfies the requirement, while a foreign director who travels in and out without permanent presence does not.

The statutory floor. Section 145(1) applies to every Singapore-incorporated company and to every foreign company that maintains a branch registration in Singapore. The company must have at least one director qualifying as ordinarily resident on the date of incorporation and must maintain that status continuously. A company that falls below the minimum because the sole resident director resigns or loses pass status is in breach and ACRA can take enforcement action including striking off.

What "ordinarily resident" covers. ACRA's local-residency requirements page identifies three qualifying categories: Singapore citizens, Singapore permanent residents, and holders of EntrePass or Employment Pass with a Singapore residential address. Foreign Identification Number (FIN) holders on other pass types are advised to verify eligibility with the issuing authority before appointment because the pass type and the underlying letter of consent govern whether the holder can serve as a director.

When a nominee is the route taken. Three patterns drive foreign-controlled companies to a nominee. The first is the holding-company structure where the operating business and senior management sit outside Singapore and no individual on the cap table or board team is a Singapore citizen, permanent resident, or pass holder. The second is the pre-relocation phase where the foreign founder is in the process of obtaining an EP or EntrePass but the company needs to incorporate before that immigration outcome lands. The third is the special-purpose vehicle (an SPV used in a fund structure or a property-holding entity, for instance) where the substantive control is offshore and the entity itself is administered locally by a CSP. The [13O family office cost article](/insights/singapore-13o-family-office-cost-2026) covers the SPV pattern in the wealth-structures context.

The 2024 framework: Section 386AC ROND, CLLPMA 2024 Central Register, and CSPA 2024 licensing

Section 386AC of the Companies Act and the Companies Regulations 2017 require every Singapore company to maintain a private Register of Nominee Directors (ROND); the CLLPMA 2024 extended the regime by requiring submission to ACRA's Central ROND from 16 June 2025 (with the initial deadline at 31 December 2025 and updates within 2 business days), and the Corporate Service Providers Act 2024 (commenced 9 June 2025) prohibits anyone from acting as nominee director by way of business unless the appointment is arranged by an ACRA-registered CSP that has assessed the nominee as fit and proper.

Section 386AC and the private register. The private ROND records, for each nominee director, the nominator's identification (full name and aliases for an individual, registered name and Unique Entity Number for a corporate nominator), residential or registered address, contact details, nationality or jurisdiction, identity-document number, the date the director became a nominee, and the date the director ceased. The director must disclose this information to the company within 30 days of becoming a nominee and within 30 days of any change. The register is kept at the company's registered office or at the office of the appointed Corporate Service Provider.

The Central ROND. From 16 June 2025, the same information is filed with ACRA's Central Register on Bizfile. Companies incorporated on or after that date with nominee directors must lodge at the time of incorporation through the "Register new business entity" eService. Existing companies were required to lodge initial Central ROND information by 31 December 2025, and subsequent changes within 2 business days. The nominee status appears in the public business profile; the nominator's full particulars are accessible only to law enforcement agencies under controlled access. Failure to lodge attracts a fine of up to S$25,000 upon conviction.

CSPA 2024 fit-and-proper. The Corporate Service Providers Act 2024 commenced on 9 June 2025 and replaces the prior Registered Filing Agent framework with the registered Corporate Service Provider regime. Under the CSPA 2024, no person may act as a nominee director by way of business unless the appointment is arranged by an ACRA-registered CSP and the CSP has assessed the nominee as fit and proper. Fit-and-proper factors include the absence of convictions involving fraud or dishonesty, the absence of undischarged bankruptcy, prior conduct and compliance history, and the competency, capacity, and capability to discharge director obligations. The CSP documents the assessment and maintains a file open to ACRA inspection.

Director duties the nominee actually carries and the indemnity question

A Singapore nominee director owes the company the same fiduciary, care-and-skill, and statutory duties as any other director under Section 157 of the Companies Act 1967 (the nominee is a director for all purposes of the duty standard), and a nominator indemnity is a contractual allocation between nominator and nominee that does not override the nominee's personal liability to creditors, regulators, or the company itself for breach of duty.

Section 157 and the unitary director standard. Section 157 of the Companies Act imposes on every director a duty to act honestly and use reasonable diligence in the discharge of the office, and prohibits an officer from making improper use of information acquired by virtue of the office. The Act does not distinguish between "executive" and "nominee" directors for purposes of duties owed; both stand in a fiduciary relationship to the company and both are exposed to personal liability if a duty is breached. Singapore courts have consistently refused to allow a nominee defence to dilute the director-duty standard: the nominee cannot say "the nominator told me to do it" as a defence to a breach of fiduciary duty.

What this means in practice. A nominee resident director who signs a company document is both the de facto and the de jure signatory. If the document constitutes a breach of director duty, the nominee is exposed in the same way the nominator would have been had the nominator signed personally. The downstream consequences include personal liability to the company for losses caused, to creditors in insolvent-trading scenarios, and to ACRA / regulatory authorities for filing offences (including the Section 155A three-strikes disqualification covered in the companion piece on [ACRA AGM and Annual Return deadlines](/insights/acra-agm-annual-return-deadlines-2026)).

The indemnity question. In professional nominee arrangements, the engagement letter records an indemnity from the nominator in favour of the nominee for losses arising from acts done at the nominator's instruction. The indemnity is contractually enforceable as between the two parties but does not bind a third party. A creditor with a Section 339 wrongful-trading claim against the nominee director does not have to defer to a nominee-nominator indemnity, and an ACRA enforcement action against the nominee for filing breaches is not defeated by the indemnity. The Anlian Group corporate services team's discipline is to limit the scope of authority granted to the nominee in writing (the nominee signs only documents within a defined scope), require nominator counter-signature where the document carries third-party exposure, and confirm in advance any non-routine instruction with the nominator before action.

	Director type	Section 145(1) resident-status basis	Public disclosure	Fit-and-proper requirement	Substantive control
Singapore-citizen director	Citizenship	Standard director profile on Bizfile	None statutory; general director-disqualification rules apply	Real	Owner-operator local company
Singapore-PR director	Permanent residence	Standard director profile	None statutory; general rules	Real	PR-status founder or local hire
EP / EntrePass holder director	Pass + Singapore residential address; check letter of consent	Standard director profile	None statutory; general rules	Real	Relocating founder; senior local hire
Nominee director (CSP-arranged)	Falls within one of the three categories above (citizen, PR, or pass-holder)	Standard profile plus nominee status flag in business profile (Central ROND, since 16 June 2025)	Yes; CSP must assess fit-and-proper under CSPA 2024 (9 June 2025)	None; nominator retains	Foreign-controlled company without local director; pre-relocation; SPV
Independent / non-executive director	Same as above by category	Standard director profile	None statutory; market practice for listed companies	Limited operational; full fiduciary	Listed-company governance; specialist board roles
Disqualified former director	Cannot be appointed during disqualification window	Bizfile records disqualification	n/a (disqualified)	n/a	Section 155A 5-year disqualification on 3+ filing offences in 5 years

Common pitfalls

Treating the nominee director as "a name on the register"
The nominee carries the full Section 157 duty of any other director, including personal liability for breach. A nominator who instructs the nominee to sign a document that breaches fiduciary duty exposes the nominee to personal claim, and the nominator-nominee indemnity does not protect the nominee against third-party creditors or ACRA enforcement. The clean discipline is to scope the nominee's signing authority in writing and obtain nominator counter-signature on third-party-facing documents.
Engaging an individual nominee instead of a CSP-arranged nominee after 9 June 2025
Under the Corporate Service Providers Act 2024, anyone acting as a nominee director by way of business must do so through an ACRA-registered CSP that has assessed them as fit and proper. Engaging a personal contact or freelance individual as a "casual nominee" is structurally non-compliant if the arrangement is by way of business and exposes both the nominator and the nominee to enforcement under the CSPA 2024. The fix is to engage only CSP-arranged nominees and to verify the CSP's ACRA registration on the public CSP register.
Missing the Central ROND 2-business-day update window
Companies must lodge Central ROND information with ACRA within 2 business days of any change (including a change in nominator details, a change in nominee status, or a cessation event). The private register can be updated administratively at the company's pace, but the Central ROND deadline is fixed. Late lodgement attracts a fine of up to S$25,000 upon conviction and is recorded in the company's compliance history.
Letting the nominee sign general powers of attorney or open-scope authorities
A general power of attorney granted to the nominee expands the nominee's signing capacity beyond the scope intended by the nominator and beyond the protective scope-limitation discipline. The Anlian Group corporate services team's standard scope is document-by-document: the nominee signs an annual return, a constitution amendment, or a specific filing under nominator instruction, but does not hold an open-scope authority that could be exercised independently.
Failing to document the CSP's fit-and-proper assessment
The CSPA 2024 requires the registered CSP to assess each proposed nominee director as fit and proper before arranging the appointment. ACRA inspection focuses on the documentary file: the assessment criteria applied, the source documents (statutory declarations, background checks), and the conclusion. A CSP that arranged a nominee appointment without a documented fit-and-proper file is exposed to regulatory action under the CSPA 2024, and the company that engaged the CSP carries the consequential exposure if the nominee is later found unfit.

Frequently asked questions

Does my Singapore private company actually need a nominee director if I am the sole foreign shareholder?: The question is whether the company already has at least one director ordinarily resident in Singapore. If you hold an Employment Pass or EntrePass with a Singapore residential address, you can be the resident director yourself and no nominee is required. If your immigration status is pending or you are not in Singapore, the company must appoint a nominee resident director to satisfy Section 145(1) of the Companies Act until your immigration outcome lands.
Can my EP-holder employee be the resident director instead of a nominee?: Yes, provided the EP / EntrePass holder consents to the appointment, holds a Singapore residential address, and the appointment is consistent with the letter of consent terms governing their pass. ACRA's local-residency guidance allows EP and EntrePass holders to serve as directors with appropriate documentation. An employee director still owes the full Section 157 duties to the company, so the engagement should be documented with role scope and reporting structure.
What is the difference between a nominee director and a registered representative?: A nominee director is a director of the company appointed to satisfy the Section 145(1) resident-director requirement. A registered representative is the local agent appointed by a foreign company that maintains a branch registration in Singapore (a different statutory mechanism under Part 11 of the Companies Act). The two roles are not interchangeable: a Singapore-incorporated subsidiary requires a nominee director if it lacks a local resident director; a foreign company's Singapore branch requires a registered representative.
What happens if the nominee director resigns?: The company has 60 days after the resignation to appoint a replacement resident director and notify ACRA through Bizfile. If the company falls below the minimum of one resident director and does not remediate, ACRA can take enforcement action including striking off. The Central ROND must be updated within 2 business days of the cessation of the nominee status, separately from the standard director-change filing on Bizfile.
What are my Central ROND filing obligations as a nominator?: The lodgement obligation sits with the company, but the nominee must disclose the nominator's particulars to the company within 30 days of appointment and within 30 days of any change. The company then files with ACRA's Central ROND within 2 business days of receipt. Companies incorporated on or after 16 June 2025 with nominee directors lodge at incorporation through the Bizfile registration flow.
How does the CSPA 2024 change who can offer nominee director services?: From 9 June 2025, only Corporate Service Providers registered with ACRA may arrange nominee director appointments by way of business, and the CSP must assess each proposed nominee as fit and proper. Existing Registered Filing Agents transitioned to CSP registration. Foreign-controlled Singapore companies that previously used informal individual nominee arrangements must restructure to engage a registered CSP, or face exposure under the CSPA 2024.
How does Anlian Group's licensed corporate services team handle nominee director appointments?: Anlian Group's licensed corporate services team is registered with ACRA as a Corporate Service Provider under FA20200346 and can arrange nominee resident director appointments under the CSPA 2024 framework following a documented fit-and-proper assessment. Engagement scope is confirmed during the [strategy call](/contact/strategy-call) and covers the nominee appointment, private and Central ROND maintenance, scope-limited signing authority, and the ACRA filings that flow from nominee status changes. The companion piece on [CDD and AML under the CSPA 2024](/insights/cdd-aml-cspa-2024-corporate-service-providers) covers the CSP-side compliance perimeter.

How Anlian Group helps

If your situation maps onto this article, we'd start with a no-pitch strategy call: 30 minutes, single-use invite, scheduled within 24 hours of your inquiry.

Request a Strategy Call →